{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:44:55Z","timestamp":1790829895348,"version":"4.1.0"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["20178S4EK9, 20209KY3Y7"],"award-info":[{"award-number":["20178S4EK9, 20209KY3Y7"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>In locally advanced (LA) laryngeal\/hypopharyngeal squamous cell carcinoma (LHSCC), larynx preservation (LP) strategies aim at the cure of the disease while preserving a functional larynx, thus avoiding total laryngectomy and the associated impact on the quality of life. In the last decades, apart from transoral and open-neck organ preservation approaches, several non-surgical regimens have been investigated: radiotherapy alone, alternate, concurrent or sequential chemoradiation, and bioradiotherapy. Despite major progress, the identification of reliable and effective predictors for treatment response remains a clinical challenge. This review examines the current state of LP in LA-LHSCC and the need for predictive factors, highlighting the importance of the PRESERVE trial in addressing this gap. The PRESERVE trial represents a pivotal initiative aimed at finding the optimal therapy for laryngeal preservation specific to each patient through a retrospective analysis of data from previous LP trials and prospectively validating findings. The goal of the PRESERVE trial is to develop a comprehensive predictive classifier that integrates clinical, molecular, and multi-omics data, thereby enhancing the precision and efficacy of patient selection for LP protocols.<\/jats:p>","DOI":"10.3389\/fonc.2024.1433333","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T05:04:36Z","timestamp":1722920676000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Is precision medicine the solution to improve organ preservation in laryngeal\/hypopharyngeal cancer? A position paper by the Preserve Research Group"],"prefix":"10.3389","volume":"14","author":[{"given":"Davide","family":"Mattavelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Wichmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Smussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Paderno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Serrahima","family":"Plana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricard Nin","family":"Mesia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micaela","family":"Compagnoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Medda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Chiocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Calza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinxiu","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Rognoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Tarricone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Stucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Lorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Gurizzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ksenia","family":"Khelik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eivind","family":"Hovig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Dietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Piazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Bossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA A Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s12105-021-01405-6","article-title":"Update from the 5th edition of the world health organization classification of head and neck tumors: hypopharynx, larynx, trachea and parapharyngeal space","volume":"16","author":"Zidar","year":"2022","journal-title":"Head Neck Pathol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy332","article-title":"Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal\/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II","volume":"29","author":"Dietz","year":"2018","journal-title":"Ann Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00625","article-title":"Laryngeal preservation approaches: considerations for new selection criteria based on the deLOS-II trial","volume":"9","author":"Dietz","year":"2019","journal-title":"Front Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s00455-009-9209-0","article-title":"Dysphagia following a total laryngectomy: the effect on quality of life, functioning, and psychological well-being","volume":"24","author":"Maclean","year":"2009","journal-title":"Dysphagia"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-023-07976-0","article-title":"Smell-related quality of life changes after total laryngectomy: a multi-centre study","volume":"280","author":"Wong","year":"2023","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2014.12.008","article-title":"Psychosocial consequences for partners of patients after total laryngectomy and for the relationship between patients and partners","volume":"51","author":"Offerman","year":"2015","journal-title":"Oral Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12030584","article-title":"Current role of total laryngectomy in the era of organ preservation","volume":"12","author":"Bozec","year":"2020","journal-title":"Cancers"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199106133242402","article-title":"Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer","volume":"324","author":"Wolf","year":"1991","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/88.13.890","article-title":"Larynx preservation in pyriform sinus cancer: preliminary results of a european organization for research and treatment of cancer phase III trial","volume":"88","author":"Lefebvre","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-023-03121-9","article-title":"Validation of a prognostic model for predicting larynx preservation outcome (TALK score) in a Southern European population","volume":"25","author":"Marruecos-Querol","year":"2023","journal-title":"Clin Transl Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11010015","article-title":"Induction chemotherapy in head and neck squamous cell carcinoma: a question of belief","volume":"11","author":"Karabajakian","year":"2018","journal-title":"Cancers (Basel)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031317","article-title":"Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer","volume":"349","author":"Forastiere","year":"2003","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.43.6097","article-title":"Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer","volume":"31","author":"Forastiere","year":"2013","journal-title":"J Clin Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.77.8001","article-title":"Different view on larynx preservation evidence-based treatment recommendations","volume":"36","author":"Licitra","year":"2018","journal-title":"J Clin Oncol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1093\/jnci\/djp007","article-title":"Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation","volume":"101","author":"Pointreau","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv368","article-title":"Long-term results of a multicenter randomized phase III trial of induction chemotherapy with cisplatin, 5-fluorouracil, \u00b1 Docetaxel for larynx preservation","volume":"108","author":"Janoray","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.3988","article-title":"Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study","volume":"31","author":"Lefebvre","year":"2013","journal-title":"J Clin Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2016.11.016","article-title":"Could the addition of cetuximab to conventional radiation therapy improve organ preservation in those patients with locally advanced larynx cancer who respond to induction chemotherapy? An organ preservation Spanish head and neck cancer cooperative group phase 2 study","volume":"97","author":"Mes\u00eda","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B20","unstructured":"Trial of Laryngeal Preservation Comparing Induced CT Followed by RT vs CT Concomitant to RT (SALTORL)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.07.011","article-title":"Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS\u2013ESMO\u2013ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Machiels","year":"2020","journal-title":"Ann Oncol"},{"key":"B22","article-title":"Do we know enough about the genetic involvement in laryngeal cancer susceptibility and prognostic outcome","volume":"60","author":"Cornean","year":"2019","journal-title":"Rom J Morphol Embryol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12092478","article-title":"Genotype of null polymorphisms in genes GSTM1, GSTT1, CYP1A1, and CYP1A1*2A (rs4646903 T>C)\/CYP1A1*2C (rs1048943 A>G) in patients with larynx cancer in southeast Spain","volume":"12","author":"S\u00e1nchez-Siles","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2021.151787","article-title":"Biomarkers of laryngeal squamous cell carcinoma: a review","volume":"54","author":"Cavaliere","year":"2021","journal-title":"Ann Diagn Pathol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29649","article-title":"The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer","volume":"137","author":"Wichmann","year":"2015","journal-title":"Int J Cancer"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.13572","article-title":"P53\/MDM2 co-expression in laryngeal squamous cell carcinoma based on digital image analysis","volume":"39","author":"Chrysovergis","year":"2019","journal-title":"Anticancer Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41419-019-1769-9","article-title":"Clinical update on head and neck cancer: molecular biology and ongoing challenges","volume":"10","author":"Alsahafi","year":"2019","journal-title":"Cell Death Dis"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.13235","article-title":"Digital analysis of BCL2 expression in laryngeal squamous cell carcinoma","volume":"39","author":"Chrysovergis","year":"2019","journal-title":"Anticancer Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2013.10.018","article-title":"p27 and BCL2 expression predicts response to chemotherapy in head and neck squamous cell carcinomas","volume":"50","author":"Moreno-Galindo","year":"2014","journal-title":"Oral Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-014-3426-3","article-title":"The prognostic value of cyclin D1 expression in head and neck squamous cell carcinoma","volume":"273","author":"Gioacchini","year":"2016","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1097\/PAI.0000000000000932","article-title":"Nuclear EGFR expression is associated with poor survival in laryngeal carcinoma","volume":"29","author":"Mariji\u0107","year":"2021","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.11544","article-title":"Combined EGFR\/ALK expression analysis in laryngeal squamous cell carcinoma","volume":"33","author":"Politi","year":"2019","journal-title":"In Vivo"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.9319","article-title":"Transforming growth factor-\u03b2 signaling in head and neck squamous cell carcinoma: Insights into cellular responses","volume":"16","author":"Pang","year":"2018","journal-title":"Oncol Lett"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10092148","article-title":"Epithelial-to-mesenchymal transition in metastasis: focus on laryngeal carcinoma","volume":"10","author":"Goulioumis","year":"2022","journal-title":"Biomedicines"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2017.04.017","article-title":"HLA traits linked to development of head and neck squamous cell carcinoma affect the progression-free survival of patients","volume":"69","author":"Wichmann","year":"2017","journal-title":"Oral Oncol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00168","article-title":"Development of a human leukocyte antigen score to predict progression-free survival in head and neck squamous cell carcinoma patients","volume":"8","author":"Wichmann","year":"2018","journal-title":"Front Oncol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1602252","article-title":"Nivolumab for recurrent squamous-cell carcinoma of the head and neck","volume":"375","author":"Ferris","year":"2016","journal-title":"N Engl J Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30066-3","article-title":"Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial","volume":"17","author":"Seiwert","year":"2016","journal-title":"Lancet Oncol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31999-8","article-title":"Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study","volume":"393","author":"Cohen","year":"2019","journal-title":"Lancet"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32591-7","article-title":"Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study","volume":"394","author":"Burtness","year":"2019","journal-title":"Lancet"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02198","article-title":"Pembrolizumab alone or with chemotherapy for recurrent\/metastatic head and neck squamous cell carcinoma in KEYNOTE-048: subgroup analysis by programmed death ligand-1 combined positive score","volume":"40","author":"Burtness","year":"2022","journal-title":"J Clin Oncol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1200\/JCO.21.02508","article-title":"Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: updated results of the phase III KEYNOTE-048 study","volume":"41","author":"Harrington","year":"2023","journal-title":"J Clin Oncol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.6008","article-title":"Immuno-chemotherapy as single treatment modality for larynx preservation (ICoLP): Co-primary endpoints and safety results","volume":"41","author":"Ferrarotto","year":"2023","journal-title":"J Clin Oncol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"6068","DOI":"10.1200\/JCO.2023.41.16_suppl.6","article-title":"Induction chemotherapy and toripalimab for larynx preservation in resectable locally advanced laryngeal\/hypopharyngeal carcinoma: Preliminary results of INSIGHT study","volume":"41","author":"Ou","year":"2023","journal-title":"J Clin Oncol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.607","article-title":"Neoadjuvant chemoimmunotherapy for the treatment of locally advanced laryngeal and hypopharyngeal squamous cell carcinoma: A single-arm phase 2 clinical trial","volume":"41","author":"Cheng","year":"2023","journal-title":"J Clin Oncol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s12105-022-01517-7","article-title":"Cancer microenvironment defines tumor-infiltrating lymphocyte density and tertiary lymphoid structure formation in laryngeal cancer","volume":"17","author":"Gkegka","year":"2023","journal-title":"Head Neck Pathol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2016.11.013","article-title":"Induction chemotherapy followed by radiotherapy for larynx preservation in advanced laryngeal and hypopharyngeal cancer: Outcome prediction after one cycle induction chemotherapy by a score based on clinical evaluation, computed tomography-based volumetry and 18F-FDG-PET\/CT","volume":"72","author":"Wichmann","year":"2017","journal-title":"Eur J Cancer"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15082246","article-title":"The incidence and the risk factors for pharyngocutaneous fistula following primary and salvage total laryngectomy","volume":"15","author":"\u0160ifrer","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1097\/JCMA.0000000000000178","article-title":"Platelet-lymphocyte and neutrophil-lymphocyte ratios: Predictive factors of response and toxicity for docetaxel-combined induction chemotherapy in advanced head and neck cancers","volume":"82","author":"Liu","year":"2019","journal-title":"J Chin Med Assoc"},{"key":"B50","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s12885-021-08128-5","article-title":"Predictive factors of toxicity of TPF induction chemotherapy for locally advanced head and neck cancers","volume":"21","author":"Bernadach","year":"2021","journal-title":"BMC Cancer"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/S0194-5998(99)70052-5","article-title":"Predictive markers for response to chemotherapy, organ preservation, and survival in patients with advanced laryngeal carcinoma","volume":"121","author":"Bradford","year":"1999","journal-title":"Otolaryngol Head Neck Surg"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-014-3134-z","article-title":"Impact of indication-shift of primary and adjuvant chemo radiation in advanced laryngeal and hypopharyngeal squamous cell carcinoma","volume":"272","author":"Boehm","year":"2015","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-013-0411-5","article-title":"Prognostic role of tumor volume for radiotherapy outcome in patient with T2 laryngeal cancer","volume":"189","author":"Rutkowski","year":"2013","journal-title":"Strahlenther Onkol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-023-07951-9","article-title":"The relation between hypoxia and proliferation biomarkers with radiosensitivity in locally advanced laryngeal cancer","volume":"280","author":"van den Bovenkamp","year":"2023","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/15592294.2015.1137414","article-title":"Gene promoter methylation signature predicts survival of head and neck squamous cell carcinoma patients","volume":"11","author":"Kostareli","year":"2016","journal-title":"Epigenetics"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29188","article-title":"Single-cycle induction chemotherapy followed by chemoradiotherapy or surgery in patients with head and neck cancer: What are the best predictors of remission and prognosis","volume":"121","author":"Semrau","year":"2015","journal-title":"Cancer"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/hed.21081","article-title":"Larynx preservation clinical trial design: Key issues and recommendations\u2014A consensus panel summary","volume":"31","author":"Lefebvre","year":"2009","journal-title":"Head Neck"},{"key":"B58","unstructured":""}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1433333\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T05:04:41Z","timestamp":1722920681000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1433333\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,6]]},"references-count":58,"alternative-id":["10.3389\/fonc.2024.1433333"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2024.1433333","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,6]]},"article-number":"1433333"}}